Caitlin E. Mills

A single-cell landscape of high-grade serous ovarian cancer

Benjamin Izar, Itay Tirosh, Elizabeth H. Stover et al. · Nature Medicine · 2020 · 478 citations · Full text

Tumor Heterogeneity, Medicine, Gynecology +5

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

Marc Hafner, Caitlin E. Mills, Kartik Subramanian et al. · Cell chemical biology · 2019 · 244 citations · Full text

Drug Target, Engineering, Translational Bioinformatics +10

Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype

Yanke Liang, Alan L. Leggett, Woojun D. Park et al. · Cell chemical biology · 2019 · 161 citations · Full text

Signal Transduction, Signaling Pathway, Cell Division +8

Targeting TBK1 to overcome resistance to cancer immunotherapy

Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 156 citations · Full text

Tumor Biology, Cancer Immunosurveillance, Immunology +5

A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines

Mario Niepel, Marc Hafner, Caitlin E. Mills et al. · Cell Systems · 2019 · 138 citations · Full text